Kamada Ltd. (NASDAQ: KMDA) (TASE: KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces financial results for the three months ended March 31, 2014.
Financial highlights of the first quarter of 2014 include:
•Total revenue increased 5% to $13.2 million from $12.6 million for the first quarter of 2013.
Help employers find you! Check out all the jobs and post your resume.
